Skip to main content

You are here

Research Project Grant (Parent R01 Clinical Trial Required) (PA-20-183)

 
Contacts and Special Interests

Release Date: May 05, 2020
Expiration Date: May 8, 2023

R01 Clinical Trial Required Participating Institutes and Centers:

  • NIH Institutes and Centers that accept Investigator-Initiated R01 applications in response to the Parent R01 Clinical Trial Required Announcement  - (PA-20-NNN)NHGRINEI, NIANIAAANIAID, NIDANIDCD, NIEHSNIGMSNIMHDNINR
  • NIH Institutes and Centers that only accept Investigator-Initiated R01 applications proposing mechanistic clinical trials in response to the Parent R01 Clinical Trial Required Announcement (PA-20-NNN)NCCIH, NHLBI, NIAMSNIMHNINDS 
  • NIH Institutes and Centers that DO NOT ACCEPT applications in response to the Parent R01 Clinical Trial Required Announcement but ONLY accept R01 applications proposing clinical trial(s) in response to their specific funding opportunity announcements: NCI, NIBIB, NICHD, NIDCR, NIDDK (PA-18-330), NLM, FIC, NCATS

NIH Institute
Or Center
Contacts

Scientific/Research Contact
Institute/Center Specific Information

Financial or Grants
Management Contact

National Center for Complementary and Integrative Health (NCCIH)

Wendy Weber, ND, PhD, MPH
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-402-1272
Email: weberwj@mail.nih.gov
 

Shelley Carow
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-594-3788
Email: carows@mail.nih.gov
 

National Eye Institute (NEI)

Ellen Liberman, PhD
National Eye Institute (NEI)
Telephone: 301- 451-2020      
Email: ellenliberman@nei.nih.gov
 
NEI only accept Clinical Trial applications proposing mechanistic studies and those designated as minimal risk. Applicants are strongly advised to contact NEI staff before submitting Clinical Trial applications to this FOA.

Karen Robinson Smith
National Eye Institute (NEI)  
Telephone: 301-451-2020 
Email: Karen.Robinson.Smith@nei.nih.gov
 

National Human Genome Research Institute (NHGRI)

Bettie J. Graham, Ph.D.
Telephone: 301-496-7531
Email: bettie_graham@nih.gov
 
NHGRI will support the development of resources, approaches, and technologies that will accelerate GENOMIC research on the structure of genomes, the biology of genomes, and the biology of disease; that will advance the science of genomic medicine; and that will incorporate genomics to improve the effectiveness of healthcare. NHGRI will also support GENOMIC research in several cross-cutting areas, including the ethical, legal and societal implications of genomics and genetics research, bioinformatics, technology development, and research training and career development.
 
 In general, NHGRI supports studies that provide generalizable methods and knowledge.  Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. NHGRI strongly encourages potential applicants to contact program staff in the early stages of developing your application. The contact information for the three scientific programs are:
Division of Genome Science: https://www.genome.gov/27550609/division-of-genome-sciences-staff/
Division of Genomic Medicine: https://www.genome.gov/27550610/division-of-genomic-medicine-staff/
Division of Genomics and Society: https://www.genome.gov/27550080/division-of-genomics-and-society/
 

Deanna L. Ingersoll
Telephone: 301-435-7858
Email: Deanna.Ingersoll@nih.gov
 

National Heart, Lung, and Blood Institute (NHLBI)

Traci Mondoro
Telephone: 301-827-8283
Email: mondorot@nhlbi.mail.gov

Melissa Green Parker
Telephone: 301-496-1051
Email: Melissa.greenparker@nih.gov

Taryn Cobb
Telephone: 301-827-8025
Email: taryn.cobb@nih.gov

National Institute on Aging (NIA)

Rene Etcheberrigaray, M.D.
National Institute on Aging (NIA)
Telephone: 301-451-9798
Email: rene.etcheberrigaray@nih.gov

Traci Lafferty
National Institute on Aging (NIA)
Telephone: 301-496-8987
Email: laffertt@nia.nih.gov
 

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Division of Epidemiology and Prevention Research
Gregory Bloss
Telephone: 301-443-3865
Email: gbloss@mail.nih.gov

Division of Medications Development Research
Joanne B. Fertig, Ph.D.
Telephone: 301-443-0635
Email: jfertig@mail.nih.gov

Division of Metabolism and Health Effects
Svetlana Radaeva, Ph.D.
Telephone: 301-443-1189
Email: sradaeva@mail.nih.gov

Division of Neuroscience and Behavior
John Matochik, Ph.D.
Telephone: 301-451-7319
Email: jmatochi@mail.nih.gov
 

Judy Fox
Telephone: 301-443-4704
Email: jfox@mail.nih.gov
 

National Institute of Allergy and Infectious Diseases (NIAID)

Ellen Goldmuntz, M.D., Ph.D.
Division of Allergy, Immunology, and Transplantation (DAIT)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3502
Email: egoldmuntz@niaid.nih.gov
 
Mr. Martin Gutierrez
Division of Acquired Immunodeficiency Syndrome (DAIDS)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-4844    
Email: mgutierrez@niaid.nih.gov
 
Greg Deye, M.D.
Division of Microbiology and Infectious Diseases (DMID) 
National Institute of Allergy and Infectious Diseases (NIAID) 
Telephone: 240-627-3371
Email: gregory.deye@nih.gov
 

Regina Kitsoulis
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2946
Email: regina.kitsoulis@nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

As announced in NOT-AR-18-008, NIAMS only accepts clinical trial applications proposing mechanistic studies for the Research Project Grant (Parent R01 Clinical Trial Required) (PA-19-055). Applicants who wish to submit clinical trial applications for consideration by NIAMS should not submit the application to this FOA.  Instead, applicants must submit clinical trial applications to one of the FOAs listed at http://www.niams.nih.gov/Funding/Clinical_Research/clinical_main.asp. Applicants are strongly advised to consult with NIAMS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity
 
 
For information regarding NIAMS supported scientific areas/programs and contacts, please see: https://www.niams.nih.gov/grants-funding/supported-scientific-areas.

Erik Edgerton
Telephone: 301-594-7760
Email:  edgertont@mail.nih.gov

National Institute on Drug Abuse (NIDA)

Beth Babecki, Ph.D.
Telephone: 301-435-1319
Email: bbabecki@nida.nih.gov
 

Pam Fleming
Email: pfleming@nida.nih.gov
Telephone: 301-480-1159
 

National Institute on Deafness and Other Communication Disorders (NIDCD)

https://www.nidcd.nih.gov/about/staff-organization/division-of-scientific-programs

Christopher Myers
Telephone: 301-402-0909
Email: myersc@mail.nih.gov

National Institute of Environmental Health Sciences (NIEHS) 

Bonnie Joubert, Ph.D.
Telephone: 984-287-3275
Email: bonnie.joubert@nih.gov
 https://www.niehs.nih.gov/funding/grants/announcements/index.cfm

Aaron Nicholas
Telephone: 984-287- 3297
Email: Aaron.Nicholas@nih.gov
 

National Institute of General Medical Sciences (NIGMS)

NIGMS supports investigator-initiated research in the following clinical research areas:

Anesthesiology
Zuzana Justinova, M.D., Ph.D.
email to zuzana.justinova@nih.gov

Clinical Pharmacology
Martha C. Garcia, Ph.D.
email to martha.garcia@nih.gov

Sepsis
Sarah E. Dunsmore, Ph.D.
email to dunsmores@mail.nih.gov

Innate Immunity and Inflammation
Xiaoli Zhao, Ph.D.
email to xiaoli.zhao@ nih.gov

Injury and Critical Illness
Xiaoli Zhao, Ph.D.
email to xiaoli.zhao@ nih.gov

Wound Healing
Martha C. Garcia, Ph.D.
email to martha.garcia@nih.gov

Additional information is available on the NIGMS website on Clinical Studies and Trials

Contacts for other research areas at NIGMS are at: https://www.nigms.nih.gov/About/pages/contactbyarea.aspx

Lisa Moeller
Email: lm236j@nih.gov
 

National Institute of Mental Health (NIMH)

As stated in NOT-MH-19-031, NIMH only accepts clinical trial applications proposing mechanistic studies under the Parent R01 Clinical Trial Required (PA-19-055). For consideration by the NIMH, applicants who wish to submit clinical trials that propose to test efficacy, effectiveness or safety should not submit to this FOA. Instead, clinical trials testing efficacy, effectiveness or safety must be submitted to one of the FOAs listed here: https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml#ctfoa. Applicants are strongly advised to consult with NIMH program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity announcement.
 
Aileen Schulte, PhD
Telephone: 301-443-1225
Email: aschulte@mail.nih.gov

Terri Jarosik
National Institute of Mental Health (NIMH)
Telephone: (301) 443-3858
Email: tjarosik@mail.nih.gov

National Institute on Minority Health and Health Disparities (NIMHD)

The National Institute on Minority Health and Health Disparities (NIMHD) will accept investigator-initiated research projects (R01) for all program areas supported by the Institute. 
Please click on links below for descriptions of NIMHD’s main research interest areas and contact information for a scientific program contact in each area:
 
Community Health and Population Sciences
Clinical and Health Services Research
Integrative Biological and Behavioral Sciences
                  

Priscilla Grant, JD
Telephone: 301-594-8412
Email:  pg38h@nih.gov
 

National Institute of Neurological Disorders and Stroke (NINDS)

Claudia Moy, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: moyc@ninds.nih.gov

As announced in NOT-NS-18-011, NINDS only accepts clinical trial applications proposing mechanistic studies for the Clinical Trial Required Parent R01 (PA-18-345). Applications that include a prospective biomedical or behavioral research study of human subjects that is designed to answer specific questions about pharmacologic, behavioral, biologic, surgical, or device interventions should be submitted to an NINDS clinical trial-specific funding announcement (listed on the NINDS website at https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/Clinical-Research). Applicants are strongly advised to consult with NINDS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity. 
 

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: ChiefGrantsManagementOfficer@ninds.nih.gov

National Institute of Nursing Research (NINR)

The National Institute of Nursing Research (NINR) will accept applications for projects in areas that are mission-relevant (http://www.ninr.nih.gov/AboutNINR/NINRMissionandStrategicPlan/). Please contact the NINR Program Director listed in the area of science in which you are interested. NINR Program Staff contacts may be found at: https://www.ninr.nih.gov/researchandfunding/desp/oep/areasofscience

Brian Albertini
Telephone: 301-594-6869
Email: albertib@mail.nih.gov

 

 
 
 
 
 
 
 
This page last updated on May 18, 2020
Technical Issues: E-mail OER Webmaster